Study of the Sexual Health of Patients Treated for Breast Cancer and Followed up in the Observatory of Fertility at Jeanne de Flandre Hospital.
Launched by UNIVERSITY HOSPITAL, LILLE · Apr 19, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the sexual health of women who have been treated for breast cancer and are being monitored at Jeanne de Flandre Hospital. The researchers want to understand how different factors, like cancer treatments, self-esteem, body image, and emotional well-being, can affect sexual health during and after treatment. Participants will fill out anonymous questionnaires to share their experiences, which will help improve support for women facing similar challenges.
To be eligible for this study, women need to be at least 18 years old, in a relationship, and diagnosed with invasive breast cancer that requires chemotherapy. They must also be receiving care at the fertility observatory and agree to participate in the study. If you join, you can expect to share your thoughts and experiences through surveys, helping to shed light on an important aspect of life after breast cancer treatment.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female from 18 years
- • In a relationship with a man or a woman
- • Developing invasive carcinoma of breast cancer
- • Planned medical therapy project by chemotherapy
- • Followed up in the Observatory of fertility
- • Patient who gave written consent to participate in the study
- • Insured Social Patient
- • Patient willing to follow all study procedures and duration
- Exclusion Criteria:
- • -
About University Hospital, Lille
University Hospital Lille is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources, multidisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking studies across various medical fields. Committed to enhancing therapeutic options and improving patient outcomes, University Hospital Lille collaborates with researchers, healthcare professionals, and industry partners to ensure rigorous scientific standards and ethical practices in all clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lille, , France
Patients applied
Trial Officials
Carine Martin, MD
Principal Investigator
University Hospital, Lille
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials